If you’ve been following the noise around AI in healthcare, you’d think that its biggest upside is summarizing patient charts or helping doctors write notes faster.
Freeing up admin time is great, but there’s more going on with AI that isn’t as immediately obvious. When it comes to AI in healthcare, the biggest financial bets are going to early-stage research and prevention.

Moving past a one-size-fits-all

For a long time, medicine has relied on life-changing, newsworthy drugs designed with the average patient in mind. But there is no such thing as an average patient. A drug that works wonders for one person may have little effect on another - or cause harmful side effects.Our bodies respond differently to the same medicines, which is why more personalized approaches to care matter.
AI can help us focus on precision instead of broad averages. Take Takeda Pharmaceutical's recent $600 million deal with AI company Insilico Medicine. They aren't spending that money to speed up patient check-in forms. They’re using smart software to map out customized medicine faster, targeting specific diseases instead of guessing what might work.

What this means for patients and doctors

Traditionally, bringing a new medicine to market takes over 10 years of trial and error. That leaves doctors with limited options for complex conditions and patients waiting far too long for answers.
Generative AI changes those odds. Instead of testing pre-existing chemical compounds one by one, computer models can simulate millions of possibilities simultaneously, reducing years of guesswork to months.
For doctors, it means moving from trying a drug to see if it works to giving patients treatments designed for the exact cause of their illness. However, for patients, especially those with rare or hard-to-treat diseases, it means getting safer, more effective treatments years or even decades earlier.

Computers can't replace real biology

Even with powerful software, we have to be careful. AI is only as smart as the information we feed it. If we train models on flawed research, we get flawed results.
Plus, a drug designed on a computer still has to work in a human body. Today, about 90% of experimental drugs fail in human trials because human systems are complicated. AI speeds up the search, but it can't replace clinical trials, real human testing, or a doctor's judgment. The essential steps needed for medical professionals to deliver on our promise to do no harm.

The real goal of AI

While AI is a great tool for healthcare, the best way forward isn't replacing human experts with computers. It's using smart tech to find targets faster, while doctors and researchers make sure those treatments actually help real people.
The future of health isn't one-size-fits-all; it’s personalized. AI can spot unique health patterns in a person's data so doctors can treat the specific cause instead of guessing with standard medicine.
By letting smart tech handle the complex numbers, human experts can focus on delivering care specific to you. That’s what it means to deliver care at the #Nof1.

Get insights like this delivered monthly.

Subscribe to the CancerGeek newsletter for exclusive perspectives on healthcare innovation, digital health trends, and more delivered straight to your inbox.